Tamoxifen inhibits the release of arachidonic acid stimulated by thapsigargin in estrogen receptor-negative A549 cells (Q42449560)

From Wikidata

Jump to navigation Jump to search

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

scientific article published on November 1997

Language	Label	Description	Also known as
English	Tamoxifen inhibits the release of arachidonic acid stimulated by thapsigargin in estrogen receptor-negative A549 cells	scientific article published on November 1997

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Tamoxifen inhibits the release of arachidonic acid stimulated by thapsigargin in estrogen receptor-negative A549 cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

1 reference

based on heuristic

inferred from title

Roderick Flower

4

object named as

R J Flower

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

author name string

J D Croxtall

1

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Q Choudhury

2

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

J O White

3

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

publication date

1 November 1997

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Biochimica et Biophysica Acta

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

1349

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

3

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

275-284

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Lipocortin 1 mediates dexamethasone-induced growth arrest of the A549 lung adenocarcinoma cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

The hepatocyte growth factor receptor kinase-mediated phosphorylation of lipocortin-1 transduces the proliferating signal of the hepatocyte growth factor

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Dexamethasone suppression of IL-1 beta-induced cyclooxygenase 2 expression is not mediated by lipocortin-1 in A549 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

The importance of phospholipase-A2 in prostaglandin biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Local variations in protein structure in the human eye lens: a Raman microspectroscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Lipocortin-1 and the control of arachidonic acid release in cell signalling. Glucocorticoids (changed from glucorticoids) inhibit G protein-dependent activation of cPLA2 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Characterization and identification of an epidermal-growth-factor-activated phospholipase A2.

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Lipocortin 1 and the control of cPLA2 activity in A549 cells. Glucocorticoids block EGF stimulation of cPLA2 phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

N-terminal peptide fragments of lipocortin-1 inhibit A549 cell growth and block EGF-induced stimulation of proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

A novel arachidonic acid-selective cytosolic PLA2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Thapsigargin, a tumor promoter, discharges intracellular Ca2+ stores by specific inhibition of the endoplasmic reticulum Ca2(+)-ATPase

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Maximal epidermal growth-factor-induced cytosolic phospholipase A2 activation in vivo requires phosphorylation followed by an increased intracellular calcium concentration.

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Tamoxifen inhibits growth of oestrogen receptor-negative A549 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Overview from the International Conference on Long-Term Tamoxifen Therapy for Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Fourteenth Gaddum Memorial Lecture. A current view of tamoxifen for the treatment and prevention of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Effects of oestrogens on cell proliferation and cell cycle kinetics. A hypothesis on the cell cycle effects of antioestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Tamoxifen and its active metabolite inhibit growth of estrogen receptor-negative MDA-MB-435 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Differential effects of estrogen, tamoxifen and the pure antiestrogen ICI 182,780 in human drug-resistant leukemia cell lines.

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Prospective controlled trial with antiestrogen drug tamoxifen in patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Clinical and radiographic response in a minority of patients with recurrent malignant gliomas treated with high-dose tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Tamoxifen: is it useful in the treatment of patients with metastatic melanoma?

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Tamoxifen: teaching an old drug new tricks?

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylenes with high affinity for the estrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Evidence that tamoxifen is a histamine antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Tamoxifen inhibits lipid peroxidation in cardiac microsomes. Comparison with liver microsomes and potential relevance to the cardiovascular benefits associated with cancer prevention and treatment by tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Tamoxifen inhibits 5-lipoxygenase in human polymorphonuclear leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesterase

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Tamoxifen blocks chloride channels. A possible mechanism for cataract formation.

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

The anti-oestrogen drug tamoxifen is an elongation inhibitor of eukaryotic protein biosynthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Tamoxifen modulates protein kinase C via oxidative stress in estrogen receptor-negative breast cancer cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Differential role of extra- and intracellular calcium in bradykinin and interleukin 1 alpha stimulation of arachidonic acid release from A549 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Calcium antagonism by the antioestrogen tamoxifen

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Tamoxifen reduces calcium currents in a clonal pituitary cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Potentiation of tamoxifen activity by verapamil in a human breast cancer cell line

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

A novel tumour promoter, thapsigargin, transiently increases cytoplasmic free Ca2+ without generation of inositol phosphates in NG115-401L neuronal cells

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

cPLA2 is phosphorylated and activated by MAP kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Phosphatidylinositol cleavage catalysed by the soluble fraction from lymphocytes. Activity at pH5.5 and pH7.0

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Enhanced synthesis de novo of phosphatidylinositol in lymphocytes treated with cationic amphiphilic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

A molecular modeling study of the interactions between the antiestrogen drug tamoxifen and several derivatives, and the calcium-binding protein calmodulin

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Thrombospondin (TSP) and transforming growth factor beta 1 (TGF-beta) promote human A549 lung carcinoma cell plasminogen activator inhibitor type 1 (PAI-1) production and stimulate tumor cell attachment in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Anti‐angiogenic activity of arachidonic acid metabolism inhibitors in angiogenesis model systems involving human microvascular endothelial cells and neovascularization in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

The estrogen antagonist tamoxifen inhibits carrageenan induced inflammation in LEW/N female rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0005-2760%2897%2900143-4

7 January 2021

Identifiers

10.1016/S0005-2760(97)00143-4

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42449560&oldid=2098065231"